16
nanotimes
Companies Facts
Companies – Summaries 3
M Twin Axial Ribbon Cable, SL8800 Series solution was announced as a recipient of R&D
Magazine’s 49th Annual R&D 100 Awards. The award recognizes 100 of the most technologically significant products and has long been a benchmark of excellence in a variety of industries – from aca- demia to government to medical to manufacturing. 3M’s newest innovation joins a distinguished group of past R&D 100 Award recipients, including the fax machine, liquid crystal display, HDTV, and company solutions 3M Aluminum Conductor Composite Rein- forced (ACCR) and 3M Cubitron™ II abrasives.
3M has completed its acquisition of Advanced Che- mistry & Technology Inc. (AC TECH), a manufac- turer of quick cure, light-weight polysulfide sealants for aerospace applications based in Garden Grove, Calif. Terms of the transaction were not disclosed. The addition of AC TECH’s range of fast-curing polysulfide sealants expands 3M’s product presence in the aerospace market for the manufacture and maintenance of commercial and military aircraft. AC TECH and 3M working together will better serve customers in the aerospace industry.
http://www.3Mconnectors.com
modeling and simulation software. The release in- corporates the first commercially available software
A
ccelrys, Inc. (NASDAQ:ACCL) announced a new release of the Discovery Studio®
life sciences
for predicting protein-protein aggregation to advance biotherapeutics research. In addition, a major update to the software’s 3D-molecular ActiveX control ena- bles researchers to display dynamic molecular visua- lizations in webpages, Microsoft Office® and Microsoft SharePoint®
applications collaboration software.
Furthermore, Accelrys announced that a continuing partnership with Toronto-based chemistry software company ACD/Labs is enabling pharmaceutical, chemical and biochemical companies around the world to work more efficiently and productively by deploying ACD/Labs analytical component collection on the Accelrys Pipeline Pilot™ enterprise R&D platform.
http://www.acdlabs.com http://www.accelrys.com
medicine, announced that the European Medicines Agency‘s (EMA) Committee for Orphan Medicinal Products (COMP) has officially granted ACT‘s human embryonic stem cell (hESC)-derived retinal pigment epithelial (RPE) cells designation as an orphan medi- cinal product for the treatment of Stargardt‘s Macular Dystrophy (SMD). This follows on the U.S. Food & Drug Administration‘s (FDA) granting of Orphan Drug De-
A
dvanced Cell Technology, Inc. (ACT; OTCBB: ACTC), a leader in the field of regenerative
11-06/07 :: June/July 2011
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104 |
Page 105 |
Page 106 |
Page 107 |
Page 108 |
Page 109 |
Page 110 |
Page 111